Practical Management Recommendations for Anti-ErbB2 Therapy with Lapatinib.
Chatsiproios
Dimitrios
D
CGG Klinik GmbH, Mannheim, Germany.
Haidinger
Renate
R
Suter
Thomas
T
Nat Rev Cancer. 2006 Oct;6(10):803-12
16990857
J Clin Oncol. 2005 Nov 1;23(31):7811-9
16258083
J Mol Cell Cardiol. 2006 Nov;41(5):845-54
17005195
J Clin Oncol. 2007 Sep 1;25(25):3859-65
17646669
J Clin Oncol. 2004 Jul 15;22(14):2918-26
15254061
Cell. 1999 Sep 3;98(5):555-8
10490095
Breast. 2004 Jun;13(3):173-83
15177418
N Engl J Med. 2006 Feb 23;354(8):809-20
16495393
Cardiovasc Toxicol. 2007;7(2):61-6
17652805
N Engl J Med. 2005 Oct 20;353(16):1659-72
16236737
N Engl J Med. 2005 Oct 20;353(16):1673-84
16236738
Oncologist. 2007 Jul;12(7):756-65
17673607
J Clin Oncol. 2002 Mar 1;20(5):1215-21
11870163
N Engl J Med. 2006 Dec 28;355(26):2733-43
17192538
J Am Coll Cardiol. 2007 Mar 13;49(10):1015-26
17349880
Circulation. 2002 Apr 2;105(13):1551-4
11927521
J Am Coll Cardiol. 2006 Oct 3;48(7):1438-47
17010808